Use of probiotic compositions in methods of treatment of self-reported performance of mental fatigue, preferably performance of low energy levels

Dietary supplementation of probiotic compositions solves self-reported mental fatigue and sleep problems, significantly improving mental fatigue and sleep quality, and providing an effective self-treatment regimen for the subsurface part of the symptomatic iceberg.

CN119095607APending Publication Date: 2024-12-06WINCLOVE HLDG BV +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202380036254.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2022-02-25
Filing Date
2023-02-24
Publication Date
2024-12-06

AI Technical Summary

Technical Problem

The prior art is difficult to effectively treat self-reported mental fatigue, especially those not reported to medical professionals, and part of the iceberg of symptoms, often relying on self-medication and lacking effective treatment options.

Method used

Provided is a probiotic composition including Lactobacillus casei W56, Lactobacillus acidophilus W22, Lactobacillus paracasei W20, Bifidobacter lactic acidophilus W51, Lactobacillus salivary W24, Lactococcus lactic acid W19, Bifidobacter lactic acid W52, plant milk Bacillus W62 and Bifidobacter bifidobacter W23, through 2 weeks of dietary supplementation, were used to improve self-reported mental fatigue, low energy levels and sleep problems.

Benefits of technology

Significantly increased the proportion of participants who did not report mental fatigue, improved energy levels and sleep quality, made more people feel good rest when they woke up, and increased the number of people who slept until dawn.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0005100679750000101
    Figure BDA0005100679750000101
  • Figure BDA0005100679750000111
    Figure BDA0005100679750000111
  • Figure BDA0005100679750000112
    Figure BDA0005100679750000112
Patent Text Reader

Abstract

The present invention relates to human subjects who have or are believed to have mental fatigue (synonymous with mental fatigue) and may aggravate due to various manifestations of low energy levels and sleep insufficiency. The invention provides a probiotic composition and a method for treating mental fatigue.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the use of a probiotic composition in self-medication of human subjects suffering from or believed to suffer from self-reported mental fatigue (synonymous with psychological fatigue) and possibly aggravated by various manifestations of low energy levels and insufficient sleep. Ishii A, Tanaka M, Watanabe Y. (Neural mechanisms of mental fatigue. Rev Neurosci. 2014; 25(4): 469-79) define psychological fatigue as a decrease in mental and / or physical activity capacity and efficiency caused by excessive mental and / or physical activity. Background Art

[0002] Knowledge about symptoms and healthcare seeking decisions sets the stage for understanding the links between healthcare systems and populations. Since the 1960s, we have witnessed a series of studies exploring the prevalence of symptoms in subjects and the proportion of subjects who seek healthcare. The situation in which the proportion of subjects who self-report symptoms is much greater than the proportion who seek professional medical treatment for the symptom was first identified by JM Last in 1963 as the "symptom iceberg" (The Iceberg "Completing the clinical picture" in general practice. Lancet. 1963; 7297(2): 28–31), and operationally defined by Hannay in 1979 (The symptom iceberg. Br J Gen Pract. 2011; 61(584): 224). The phenomenon describes two components - the "underwater (self-reported) component", which includes the majority of symptom experiences (at least reported to themselves) that do not come to the attention of general practitioners (GPs) or the medical profession at large and can be self-medicated; and the "above-water component", which represents the proportion of symptoms that are presented to doctors as a result of seeking medical treatment from medical professionals. As reviewed by Elnegaard et al. (Self-reported symptoms and healthcare seeking in the general population-exploring "The Symptom Iceberg", BMC Public Health. 2015; 15: 685), studies have shown that the decision-making process of subjects regarding seeking healthcare for symptoms is complex and depends on a variety of different factors that may differ between men and women. Elnegaard et al. (supra) reported the incidence of 44 self-reported (sometimes also called patient-reported) symptoms in a group of 100,000 randomly selected subjects and classified these symptoms according to how often they caused patients to contact their general practitioners (GPs). The largest proportion of GP contacts was observed among individuals who reported blood in the urine, at 73.2%, while 11.4% of individuals with increased waist circumference reported contacting their GP.

[0003] According to the American Psychological Association’s (APA) 2021 Work and Well-Being Survey of 1,501 adult U.S. workers, 79% of employees experienced self-reported work-related stress in the month prior to the survey. In the survey, nearly three-fifths of employees reported negative effects of work-related stress, including lack of interest, motivation, or energy (26%) and not working hard (19%). Meanwhile, 36% reported cognitive fatigue, 32% reported mental fatigue, and a shocking 44% reported physical fatigue—a 38% increase since 2019. The phenomenon has even been called “the other epidemic.” The past few years have been extremely stressful, both individually and collectively. Global pandemics, social unrest, and, more recently, wars in Europe have increasingly led to reports of mental fatigue. Job changes, loss of loved ones, isolation, and a constant stream of negative news have left many people feeling mentally exhausted and unsure how to recover from this chronic state of tension.

[0004] As defined by the NHS, stress is the body's response to feeling threatened or pressured. Stress is very common and can motivate us to achieve our goals in everyday life and help us meet the demands of home, work and family life. But too much stress can affect our emotions, bodies and relationships - especially when it's beyond our control. It can make us feel anxious and irritable, and affect our self-esteem. Exposure to high levels of stress for long periods of time can also lead to feelings of mental fatigue.

[0005] Care should be taken to distinguish between people with (self-reported) mental fatigue and those with (validly diagnosed) clinical depression. Clinical depression is defined as a mood disorder that causes persistent feelings of sadness and loss of interest and can be diagnosed according to the International Statistical Classification of Diseases and Related Health Problems (ICD-10) guidelines (Sheehan et al., The Mini-International Neuropsychiatric Interview (MINI): The Development and Validation of a Structured Diagnostic Psychiatric Interview for DSM-IV and ICD-10. J. Clin. Psychiatry 1998, 59 (Suppl. 20), 22–33), or according to a validated psychiatric diagnostic tool, such as the Leiden Depression Index Revisited (LEIDS-R), as described, for example, in US20180271919 and in a recent (published after the priority date of this application) study by Kreuzer et al. (The PROVIT Study—Effects of Multispecies Probiotic Add-on Treatment on Metabolomics in Major Depressive Disorder—A Randomized, Placebo-Controlled Trial. Metabolites 2022,12,770.). The widely used MINI is a brief, structured interview administered by medical professionals that is designed to screen for several psychiatric disorders and medication use. Medical clinicians use the MINI to diagnose clinical depression, but it is not typically used by laypeople or women when they self-report the disorder. Clinical depression, also known as major depressive disorder (MDD), affects how you feel, think, and behave, and can lead to a variety of serious emotional and physical problems.

[0006] US20180271919 and Kreuzer et al. (supra) do not mention nor treat (self-reported) mental fatigue. For mental fatigue, most problems are work-related, and personal adjustments in work or rest usually help. However, for depression, such personal adjustments are usually not helpful, there is no causal relationship with stress, and other treatments such as (psychological) therapy or medication may be needed. In addition, depression has certain symptoms that mental fatigue does not usually show, including low self-esteem, hopelessness and / or suicidal thoughts.

[0007] Fatigue can also be classified as physical or mental. Mental fatigue manifests as underlying impaired cognitive function and is one of the leading causes of accidents in modern society. Recently, it has been shown that the neural mechanisms of mental fatigue associated with cognitive task performance are more complex than previously thought and that mental fatigue is not simply caused by impaired activity in task-related brain areas. Increasing evidence supports the existence of mental facilitation and inhibition systems. These systems are involved in the neural mechanisms of mental fatigue and modulate activity in task-related brain areas to regulate cognitive task performance. In short, mental fatigue occurs when your brain receives too much stimulation or has to maintain high-intensity activity without rest.

[0008] If a person regularly works or studies for long hours, takes little or no breaks, spends many hours a day dealing with overwhelming responsibilities, lives with mental health symptoms, and spends a lot of energy thinking about problems, worrying, or feeling overwhelmed every day, then he or she may be experiencing mental fatigue, sometimes called psychological fatigue. It is not uncommon to feel physically tired from time to time, and the same is true for mental fatigue or psychological fatigue. However, persistent mental fatigue can affect a person's ability to think, solve problems, or process and regulate emotions. Eventually, it can even make it challenging for a person to go about their daily life and relationships. "Mental" tends to refer to cognitive skills, such as thinking, remembering, making decisions, and problem solving. "Emotional," on the other hand, is about feelings, including your ability to identify, process, and express them. In addition, many people have come to accept the idea that feeling mentally tired, weak, or exhausted is the price you pay for having a busy social life, personal life, and career. However, you don't have to fight fatigue every day. Many people, especially women, don't consider fatigue to be something they should seek medical attention for. In their view, it's just a symptom of a busy life, but if you have a healthy lifestyle and are generally healthy, you shouldn't be bothered by fatigue. When women say they are tired all the time, there is often an underlying problem. Physical fatigue is caused by muscle fatigue caused by high-intensity physical activity, while mental fatigue is caused by prolonged cognitive activity, which can impair cognitive performance. Mental fatigue can manifest as drowsiness with an inability to fall asleep and rest, sleepiness, or fatigue with directed attention (Marcora SM, Staiano W, Manning V. "Mental fatigue impairs physical performance in humans". Journal of Applied Physiology. 106(3):857–864). Mental fatigue may also impair physical performance. (Martin K, Meeusen R, Thompson KG, Keegan R, Rattray B. "Mental Fatigue Impairs Endurance Performance: A Physiological Explanation". Sports Med. 48(9):2041–2051).

[0009] Chronic stress may affect a person's psychological well-being due to a reduced production of serotonin. While only a small amount of serotonin is produced in the liver, spleen and brain, the intestinal mucosa provides up to 95% of this messenger substance. The starting material here is 5-hydroxy-tryptophan (5-HTP), the precursor of which is L-tryptophan. With the help of vitamin B6 and magnesium, 5-HTP is converted into serotonin. When we are under stress, this pathway no longer works properly. As a result, serotonin is not produced enough, which can lead to psychiatric disorders. Recent research has focused on the importance of the intestinal microbiota in the two-way communication between the gut and the brain. The signaling molecules produced by the intestinal microbiota have an important influence on the regulation of brain function as well as on human mood and behavior, as indicated by new studies on the use of probiotics in healthy young people and patients with psychiatric disorders. The concept of the gut-brain axis represents an important approach to the development of new therapeutic strategies for psychiatric disorders and at the same time helps to optimize cognitive function in these patients, thus greatly improving the quality of life.

[0010] A probiotic is a living microorganism that, when present in sufficient amounts, can bring health benefits to the host. Probiotics can be taken in the form of commercially produced dietary supplements, such as probiotic powders, capsules, tablets, or fortified dietary products. Because the beneficial effects of probiotics on mental health have been demonstrated, they are also called "psychobiotics". Throughout the literature, there seem to be two main hypotheses that propose possible mechanisms by which probiotics exert their effects on mood symptoms. The theory involves the regulation of serotonin metabolism and the regulation of inflammatory markers. The first hypothesis has been demonstrated by Wallace C. et al., "The effects of probiotics on depressive symptoms in humans: a systematic review" (Ann Gen Psychiatry. 2017; 16: 14). Probiotics in the gastrointestinal tract have been shown to affect serotonin levels in the blood and brain via the gut-brain axis, and some people believe that vitamin B or milk-derived products used with psychobiotics help affect these levels.

[0011] The second hypothesis has been demonstrated by Reiter, A. et al., "Interleukin-6 Gene Expression Changes after a 4-Week Intake of a Multispecies Probiotic in Major Depressive Disorder—Preliminary Results of the PROVIT Study" (Nutrients 2020, 12, 2575), a randomized, placebo-controlled, multispecies probiotic study on depressed individuals. The probiotic intervention group showed a decrease in the expression level of the pro-inflammatory IL-6 gene, while the placebo group showed an increase in the expression level of the IL-6 gene.

[0012] Probiotics can also be used as a useful complementary therapy for psychotherapy. Ansare F. et al., "The effects of probiotics and prebiotics on mental disorders: a review on depression, anxiety, Alzheimer and autism spectrum disorders" (Curr Pharm Biotechnol. 2020; 21: 555) showed that probiotics can improve mental health and psychological function and can be provided as a new drug for common mental disorders. Clinicians can recommend probiotics to their patients. Dolan et al. (Probiotics and Disease: A Comprehensive Summary-Part 1, Mental and Neurological Health. Integr Med (Encinitas). 2016 Oct; 15 (5): 46-58.) provide a literature review of disease-specific probiotic strains studied in published clinical trials. It is reported that the plant lactobacillus JYLP-326 strain is used to prepare a powder product for improving sleep (claimed), suppressing anxiety and depression symptoms, and relieving mental fatigue (CN 110 792451A). Lalitsuradej et al. (16th ECTI-CON 2019) provided a study on the effects of Lactobacillus paracasei HII01 on cortisol in fatigued subjects and believed that further research must be conducted to reveal the health benefits of this strain. Daisuke Sawada et al. (Journal of Functional Foods 57, 2019, 465-476) showed that daily intake of Lactobacillus gasseri CP2305 can alleviate fatigue and stress-related symptoms in male college relay runners.Two studies that more directly address neuroendocrine imbalances in chronic fatigue syndrome suggest that supplementation with certain Lactobacillus species may indeed reduce anxiety symptoms (Rao AV, Bested AC, Beaulne TM, et al. A randomized, double-blind, placebo-controlled pilot study of a probiotic inemotional symptoms of chronic fatigue syndrome, whereas of other Lactobacillus strains or combinations thereof such effects are not known. Gut Pathogen. 2009; 1:6; O'Sullivan E, Barrett E, Grenham S, et al. Brain-derived neurotrophic factor (BDNF) is of interest because of its putative role in stress and psychiatric disorders). Sullivan et al. studied BDNF expression in the hippocampus of maternally separated rats (Does Bifidobacterium breve 6330 alter BDNF levels? Benef. Microbes. 2011; 2(3): 199), and although Bifidobacterium breve 6330 affected BDNF in normal animals, it had no significant effect on BDNF in maternally separated stressed animals. This opposing effect is not known for other Bifidobacterium strains or combinations thereof. Galland (The gutmicrobiome and the brain. J Med Food. 2014; 17(12): 1261–1272.) showed that supplementation with Bacteroides fragilis also reduced anxiety levels, while this effect is not known for other Bacteroides strains or combinations thereof. Summary of the invention

[0013] The present invention provides a probiotic composition for use in treating self-reported mental fatigue-related conditions in humans. Thus, the present invention provides a self-medication use that targets the subsurface portion of the symptom iceberg (as discussed above); those conditions and symptoms that are not typically reported to GPs or other medical professionals and for which treatment relies primarily on self-medication. Preferably, the composition comprises Lactobacillus casei W56, Lactobacillus acidophilus W22, Lactobacillus paracasei W20, Bifidobacterium lactis W51, Lactobacillus salivarius W24, Lactococcus lactis W19, Bifidobacterium lactis W52, Lactobacillus plantarum W62 and Bifidobacterium bifidum W23. Figure 1 As further shown in the , the effect of 2 weeks of dietary supplementation with probiotics as provided herein on the number of participants reporting improved self-reported mental fatigue, when the use of this composition in a two-week treatment method was tested in a large group (effective size n=9897) recording self-reported manifestations of mental disorders, it was found that it doubled the proportion of participants who reported little mental fatigue, and demonstrated the benefit of the probiotic composition in reducing mental fatigue symptoms. The present invention also provides a treatment method for the underwater part of the symptom iceberg; a treatment method for those conditions and symptoms that are not typically reported to GPs or other medical professionals, and the treatment relies mainly on self-medication. In particular, the present invention provides a treatment method for self-reported mental fatigue-related conditions in humans, the method comprising providing humans with a probiotic composition as provided herein. Figure 1 The composition shown, wherein the condition includes mental fatigue. Preferably, the composition comprises Lactobacillus casei W56, Lactobacillus acidophilus W22, Lactobacillus paracasei W20, Bifidobacterium lactis W51, Lactobacillus salivarius W24, Lactococcus lactis W19, Bifidobacterium lactis W52, Lactobacillus plantarum W62 and Bifidobacterium bifidum W23. In another preferred embodiment, the present invention provides a self-medication use of the composition and treatment method, wherein the condition includes low energy level (see Figure 2 , the effect of 2 weeks of dietary supplementation with probiotics as provided herein on the number of participants reporting an improvement in the feeling of self-reported energy levels). Preferably, the composition comprises Lactobacillus casei W56, Lactobacillus acidophilus W22, Lactobacillus paracasei W20, Bifidobacterium lactis W51, Lactobacillus salivarius W24, Lactococcus lactis W19, Bifidobacterium lactis W52, Lactobacillus plantarum W62 and Bifidobacterium bifidum W23. In another embodiment, the present invention also provides a method of treating by self-medication using a composition according to the present invention, wherein the subject performing the self-medication more often feels well rested upon waking up (see Figure 3: Effect of 2 weeks of dietary supplementation with probiotics as provided herein on the number of participants who feel well rested upon waking). Preferably, the composition comprises Lactobacillus casei W56, Lactobacillus acidophilus W22, Lactobacillus paracasei W20, Bifidobacterium lactis W51, Lactobacillus salivarius W24, Lactococcus lactis W19, Bifidobacterium lactis W52, Lactobacillus plantarum W62 and Bifidobacterium bifidum W23. In another embodiment, the present invention also provides a method of self-medication by using a composition according to the present invention, wherein the subject who performs the self-medication has a good sleep more often (see Figure 4 : The effect of 2 weeks of dietary supplementation with probiotics as provided herein on the number of participants with good sleep). Preferably, the composition comprises Lactobacillus casei W56, Lactobacillus acidophilus W22, Lactobacillus paracasei W20, Bifidobacterium lactis W51, Lactobacillus salivarius W24, Lactococcus lactis W19, Bifidobacterium lactis W52, Lactobacillus plantarum W62 and Bifidobacterium bifidum W23. In another embodiment, the present invention also provides a method of self-medication by using the composition according to the present invention, wherein the subject who performs the self-medication can sleep through the night more often (see Figure 5 : The effect of 2 weeks of dietary supplementation with probiotics as provided herein on the number of participants who slept through the night). Preferably, the composition comprises Lactobacillus casei W56, Lactobacillus acidophilus W22, Lactobacillus paracasei W20, Bifidobacterium lactis W51, Lactobacillus salivarius W24, Lactococcus lactis W19, Bifidobacterium lactis W52, Lactobacillus plantarum W62 and Bifidobacterium bifidum W23. Participants (n=14503, final assessment n=9897) were recruited in pharmacies and doctors' offices to conduct self-reports and fill out several questionnaires related to psychological resilience. In another embodiment, it is preferred that tryptophan is provided to the composition or supplement. In yet another embodiment, it is preferred that a milk-derived product is provided to the composition or supplement. In yet another embodiment, it is preferred that a vitamin B product is provided to the composition or supplement. In another embodiment, it is preferred that oral supplementation of the composition can regulate serotonin levels in human blood.

[0014] In another embodiment, the present invention provides a probiotic composition for treating a condition associated with low energy levels in a human. Figure 2 As further shown in , the composition as provided herein resulted in almost twice as many participants feeling energetic most or all the time. Figures 3 to 5 It was further shown that the composition was also able to address the mental issues and nearly doubled the number of people who felt well-rested upon waking, increased the number of people who had a good night's sleep, and increased the number of people who slept through the night by a third.

[0015] Preferably, the composition for treating mental fatigue-related conditions in humans and / or for treating low energy level-related conditions in humans and for improving self-reported sleep (such as in the condition of mental fatigue or having to deal with self-reported overwhelming responsibilities) comprises a multi-species probiotic composition, preferably comprising at least one, more preferably at least two species selected from the following group: Lactobacillus casei, Lactobacillus acidophilus, Lactobacillus paracasei, Bifidobacterium lactis, Lactobacillus salivarius, Lactococcus lactis, Lactobacillus plantarum and Bifidobacterium bifidum, more preferably comprising at least one, more preferably two species selected from the following group: Lactobacillus casei W56, Lactobacillus acidophilus W22, Lactobacillus paracasei W20, Bifidobacterium lactis W51, Lactobacillus salivarius W24, Lactococcus lactis W19, Bifidobacterium lactis W52, Lactobacillus plantarum W62 and Bifidobacterium bifidum W23. In certain embodiments of the present invention, it is preferred that the intake of the composition as provided herein is accompanied by vitamin B or a milk-derived product.

[0016] Furthermore, it is more preferred that the composition comprises at least three, preferably at least four, more preferably at least five, more preferably at least six, and most preferably at least seven species selected from the following group: Lactobacillus casei, Lactobacillus acidophilus, Lactobacillus paracasei, Bifidobacterium lactis, Lactobacillus salivarius, Lactococcus lactis, Lactobacillus plantarum and Bifidobacterium bifidum.

[0017] In a preferred embodiment, the present invention provides a composition for treating self-reported mental disorder-related conditions, preferably for treating mental fatigue in humans, the composition comprising at least six species selected from the following group: Lactobacillus acidophilus, Lactobacillus paracasei, Bifidobacterium lactis, Lactobacillus salivarius, Lactococcus lactis, Lactobacillus plantarum and Bifidobacterium bifidum. The present invention also provides a method for treating mental disorder-related conditions, preferably mental fatigue, the method comprising providing a composition according to the above-mentioned bacterial species to humans.

[0018] In a preferred embodiment, the present invention provides a composition for treating self-reported mental disorder-related conditions, preferably for treating mental fatigue in humans, the composition comprising at least six species selected from the following group: Lactobacillus casei, Lactobacillus paracasei, Bifidobacterium lactis, Lactobacillus salivarius, Lactococcus lactis, Lactobacillus plantarum and Bifidobacterium bifidum. The present invention also provides a method for treating mental disorder-related conditions, preferably mental fatigue, the method comprising providing a composition according to the above-mentioned bacterial species to humans.

[0019] In a preferred embodiment, the present invention provides a composition for treating self-reported mental disorder-related conditions, preferably mental fatigue in humans, the composition comprising at least six species selected from the following group: Lactobacillus casei, Lactobacillus acidophilus, Bifidobacterium lactis, Lactobacillus salivarius, Lactococcus lactis, Lactobacillus plantarum and Bifidobacterium bifidum. The present invention also provides a method for treating mental disorder-related conditions, preferably mental fatigue, the method comprising providing a composition according to the above-mentioned bacterial species to humans.

[0020] In a preferred embodiment, the present invention provides a composition for treating self-reported mental disorder-related conditions, preferably for treating mental fatigue in humans, the composition comprising at least six species selected from the following group: Lactobacillus casei, Lactobacillus acidophilus, Lactobacillus paracasei, Lactobacillus salivarius, Lactococcus lactis, Lactobacillus plantarum and Bifidobacterium bifidum. The present invention also provides a method for treating mental disorder-related conditions, preferably mental fatigue, the method comprising providing a composition according to the above-mentioned bacterial species to humans.

[0021] In a preferred embodiment, the present invention provides a composition for treating self-reported mental disorder-related conditions, preferably for treating mental fatigue in humans, the composition comprising at least six species selected from the following group: Lactobacillus casei, Lactobacillus acidophilus, Lactobacillus paracasei, Bifidobacterium lactis, Lactococcus lactis, Lactobacillus plantarum and Bifidobacterium bifidum. The present invention also provides a method for treating mental disorder-related conditions, preferably mental fatigue, the method comprising providing a composition according to the above-mentioned bacterial species to humans.

[0022] In a preferred embodiment, the present invention provides a composition for treating self-reported mental disorder-related conditions, preferably for treating mental fatigue in humans, the composition comprising at least six species selected from the following group: Lactobacillus casei, Lactobacillus acidophilus, Lactobacillus paracasei, Bifidobacterium lactis, Lactobacillus salivarius, Lactobacillus plantarum and Bifidobacterium bifidum. The present invention also provides a method for treating mental disorder-related conditions, preferably mental fatigue, the method comprising providing a composition according to the above-mentioned bacterial species to humans.

[0023] In a preferred embodiment, the present invention provides a composition for treating self-reported mental disorder-related conditions, preferably for treating mental fatigue in humans, the composition comprising at least six species selected from the following group: Lactobacillus casei, Lactobacillus acidophilus, Lactobacillus paracasei, Bifidobacterium lactis, Lactobacillus salivarius, Lactococcus lactis and Lactobacillus plantarum. The present invention also provides a method for treating mental disorder-related conditions, preferably mental fatigue, the method comprising providing a composition according to the above-mentioned bacterial species to humans.

[0024] Preferred is a composition for treating self-reported mental disorder-related conditions in humans, wherein oral supplementation of the composition can increase human serotonin levels, the composition comprising Lactobacillus casei W56, Lactobacillus acidophilus W22, Lactobacillus paracasei W20, Bifidobacterium lactis W51, Lactobacillus salivarius W24, Lactococcus lactis W19, Bifidobacterium lactis W52, Lactobacillus plantarum W62 and Bifidobacterium bifidum W23. The present invention also provides a method for treating mental disorder-related conditions, preferably mental fatigue, comprising providing a composition according to the above-mentioned bacterial species to a human.

[0025] This probiotic composition can be obtained by Winclove and / or Allergosan, which has the proven test results as shown in the accompanying drawings and discussed above. Probiotic supplements can be provided by "InstituteAllergosan" in Austria and / or Winclove BV in Amsterdam, the Netherlands. As a commercially available dietary supplement, it contains up to nine bacterial strains (species), with at least 7.5 billion organisms per 1 portion (3g). The bacterial strains (species) are Bifidobacterium bifidum W23, Bifidobacterium lactis W51, Bifidobacterium lactis W52, Lactobacillus acidophilus W22, Lactobacillus casei W56, Lactobacillus paracasei W20, Lactobacillus plantarum W62, Lactobacillus salivarius W24 and Lactococcus lactis W19. Such compositions as provided herein are preferably used to treat self-reported mental disorders, and can be mixed with, for example, B vitamins to enhance gut-brain activity. BRIEF DESCRIPTION OF THE DRAWINGS

[0026] Figure 1 : Effect of 2 weeks of dietary supplementation with probiotics as provided herein on the number of participants reporting improvements in self-reported mental fatigue. Participants (n=9897) were recruited in pharmacies and physicians' offices to self-report and complete several questionnaires related to psychological resilience.

[0027] Figure 2 : Effect of 2 weeks of dietary supplementation with probiotics as provided herein on the number of participants reporting improved feelings of self-reported energy levels. Participants (n=9897) were recruited in pharmacies and doctors' offices to self-report and complete several questionnaires related to psychological resilience.

[0028] Figure 3 : Effect of 2 weeks of dietary supplementation with probiotics as provided herein on the number of participants feeling well rested upon waking. Participants (n=9897) were recruited in pharmacies and doctors' offices to self-report and complete several questionnaires related to psychological resilience.

[0029] Figure 4: Effect of 2 weeks of dietary supplementation with probiotics as provided herein on the number of participants with good sleep. Participants (n=9897) were recruited in pharmacies and doctors' offices to self-report and fill out several questionnaires related to psychological resilience.

[0030] Figure 5 : Effect of 2 weeks of dietary supplementation with probiotics as provided herein on the number of participants sleeping through the night. Participants (n=9897) were recruited in pharmacies and doctors' offices to self-report and complete several questionnaires related to psychological resilience. DETAILED DESCRIPTION

[0031] Participants (n = 14,503, final assessment n = 9,897) were recruited in pharmacies and doctors' offices in Austria between May 2020 and June 2021 to self-report and fill out several questionnaires related to psychological resilience. There were no restrictions on age or health indication, except for instructions on the product packaging.

[0032] The mean age of the combined population was 43 years with a standard deviation of 12 years. The main indication for probiotic supplementation was psychological resilience during the COVID-19 pandemic.

[0033] Participants were asked to take a probiotic composition containing strains Bifidobacterium bifidum W23, Bifidobacterium lactis W51, Bifidobacterium lactis W52, Lactobacillus acidophilus W22, Lactobacillus casei W56, Lactobacillus paracasei W20, Lactobacillus plantarum W62, Lactobacillus salivarius W24 and Lactobacillus lactis W19 for two weeks according to the user instructions on the package. Participants self-reported and filled in a health and well-being questionnaire at baseline and after 2 weeks of consuming the probiotic composition. The basic elements of the questionnaire are given in the following pages.

[0034] Questionnaire

[0035] Before you start taking probiotics on a daily basis, please answer Part A of the following questionnaire. Below, you will find several statements. Please read each statement and fill in the scale next to it according to how true you think the statement is for your life right now.

[0036]

[0037] In the next question, we want to know how you are feeling right now and how you have been feeling over the past few weeks. Please tick the box next to which answer best describes your current situation. In the past few weeks, how often have you been / felt the following?

[0038]

[0039] Finally, we asked you to provide some statistics and general information about your gastrointestinal health.

[0040]

[0041] Please follow the instructions in the following paragraphs to start taking the probiotic composition. Intake advice: Once a day, stir 1 sachet (=3g) in about 125ml of water or milk product (both at room temperature), wait 1 minute (activation time), then stir again and drink. Adding vitamin B products is optional.

[0042] We want to know how you feel after 2 weeks of taking probiotics: Below, you will find several statements again in Part B. Please read each statement and fill in the scale next to it according to how true you think the statement is for your life right now.

[0043]

Claims

1. A probiotic composition for use in treating self-reported symptoms of a psychiatric disorder in a human.

2. The composition according to claim 1, wherein the composition is a multi-species probiotic composition.

3. The composition according to claim 2, comprising at least one species selected from the group consisting of Lactobacillus casei, Lactobacillus acidophilus, Lactobacillus paracasei, Bifidobacterium lactis, Lactobacillus salivarius, Lactococcus lactis, Lactobacillus plantarum and Bifidobacterium bifidum.

4. The composition according to any one of claims 1 to 3, wherein the condition comprises mental fatigue.

5. The composition of any one of claims 1 to 4, wherein the condition further comprises low energy levels.

6. The composition of any one of claims 1 to 5, wherein the condition further comprises self-reported sleep disturbance.

7. The composition according to any one of claims 1 to 6, comprising at least two species selected from the following group: Lactobacillus casei W56, Lactobacillus acidophilus W22, Lactobacillus paracasei W20, Bifidobacterium lactis W51, Lactobacillus salivarius W24, Lactococcus lactis W19, Bifidobacterium lactis W52, Lactobacillus plantarum W62 and Bifidobacterium bifidum W23.

8. The composition according to any one of claims 1 to 7, comprising at least three, preferably at least 4, more preferably at least 5, more preferably at least 6, most preferably 7 species selected from the following group: Lactobacillus casei, Lactobacillus acidophilus, Lactobacillus paracasei, Bifidobacterium lactis, Lactobacillus salivarius, Lactococcus lactis, Lactobacillus plantarum and Bifidobacterium bifidum.

9. The composition according to any one of claims 1 to 8, comprising Lactobacillus casei W56, Lactobacillus acidophilus W22, Lactobacillus paracasei W20, Bifidobacterium lactis W51, Lactobacillus salivarius W24, Lactococcus lactis W19, Bifidobacterium lactis W52, Lactobacillus plantarum W62 and Bifidobacterium bifidum W23.

10. The composition according to any one of claims 1 to 9, supplemented with tryptophan.

11. The composition according to any one of claims 1 to 10, supplemented with a milk-derived product.

12. A composition according to any one of claims 1 to 11 supplemented with a vitamin B product.

13. A method for treating a condition associated with a mental disorder, the method comprising providing a composition according to any one of claims 1 to 10 to a human being.

14. The method of claim 13, wherein the condition comprises mental fatigue.

15. The method of claim 13 or 14, wherein the condition comprises low energy levels.

16. The method of any one of claims 11 to 15, further comprising providing tryptophan to the supplement.

17. The method according to any one of claims 11 to 16, further comprising providing a milk-derived product to the supplement.

18. The method of any one of claims 12 to 17, further comprising providing a vitamin B product to the supplement.